Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Louis

Showing results (251-260 of 290) with videos related to

Pageof 29
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2020
Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID groupMaria Nachury, Yoram Bouhnik, Melanie Serrero, et al.
Plos One|September 29, 2009
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitisAlexandra-Chloé Villani, Mathieu Lemire, Edouard Louis, et al.
Journal of Crohn'S & Colitis|September 8, 2025
Blood proteomic signatures associated with disease activity in inflammatory bowel diseasesMaëva Veyssière, Nassim Hammoudi, Lionel Le Bourhis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2023
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAIDRose Al Bacha, Yoram Bouhnik, Melanie Serrero, et al.
Gastroenterology|January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's DiseaseGeert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAIDYoram Bouhnik, Guillaume Pineton de Chambrun, Jérôme Lambert, et al.
Inflammatory Bowel Diseases|October 12, 2021
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAIDCatherine Reenaers, Arnaud de Roover, Laurent Kohnen, et al.
Inflammatory Bowel Diseases|July 12, 2017
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)Lucas Wauters, Françoise Smets, Elisabeth De Greef, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.
Gastroenterology|February 5, 2022
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial ResultsGeert R D'Haens, William J Sandborn, Edward V Loftus, et al.
Pageof 29

Showing results (251-260 of 290) with videos related to

Sort By:
Pageof 29
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 14, 2020
Patients' real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID groupMaria Nachury, Yoram Bouhnik, Melanie Serrero, et al.
Plos One|September 29, 2009
Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitisAlexandra-Chloé Villani, Mathieu Lemire, Edouard Louis, et al.
Journal of Crohn'S & Colitis|September 8, 2025
Blood proteomic signatures associated with disease activity in inflammatory bowel diseasesMaëva Veyssière, Nassim Hammoudi, Lionel Le Bourhis, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 28, 2023
Obesity in adult patients with inflammatory bowel disease: Clinical features and impact on disability. A cross-sectional survey from the GETAIDRose Al Bacha, Yoram Bouhnik, Melanie Serrero, et al.
Gastroenterology|January 11, 2018
Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn's DiseaseGeert D'Haens, Severine Vermeire, Guy Lambrecht, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
Adalimumab in Biologic-naïve Patients With Crohn's Disease After Resolution of an Intra-abdominal Abscess: A Prospective Study From the GETAIDYoram Bouhnik, Guillaume Pineton de Chambrun, Jérôme Lambert, et al.
Inflammatory Bowel Diseases|October 12, 2021
Bariatric Surgery in Patients With Inflammatory Bowel Disease: A Case-Control Study from the GETAIDCatherine Reenaers, Arnaud de Roover, Laurent Kohnen, et al.
Inflammatory Bowel Diseases|July 12, 2017
Long-term Outcomes with Anti-TNF Therapy and Accelerated Step-up in the Prospective Pediatric Belgian Crohn's Disease Registry (BELCRO)Lucas Wauters, Françoise Smets, Elisabeth De Greef, et al.
The Lancet. Gastroenterology & Hepatology|July 30, 2018
Risankizumab in patients with moderate to severe Crohn's disease: an open-label extension studyBrian G Feagan, Julián Panés, Marc Ferrante, et al.
Gastroenterology|February 5, 2022
Higher vs Standard Adalimumab Induction Dosing Regimens and Two Maintenance Strategies: Randomized SERENE CD Trial ResultsGeert R D'Haens, William J Sandborn, Edward V Loftus, et al.
Pageof 29